World Journal of Laparoscopic Surgery

Register      Login

VOLUME 12 , ISSUE 1 ( January-April, 2019 ) > List of Articles

RESEARCH ARTICLE

Comparative Analysis of Surgical and Pathological Outcomes between Laparoscopic and Open Rectal Cancer Surgeries: Single Institution Experience

Jagadeesan G Mani

Keywords : Laparoscopic resections, Pathological outcomes, Perioperative outcomes, Rectal cancers, Retrospective comparative study

Citation Information : Mani JG. Comparative Analysis of Surgical and Pathological Outcomes between Laparoscopic and Open Rectal Cancer Surgeries: Single Institution Experience. World J Lap Surg 2019; 12 (1):19-24.

DOI: 10.5005/jp-journals-10033-1361

License: CC BY-NC 4.0

Published Online: 01-06-2018

Copyright Statement:  Copyright © 2019; The Author(s).


Abstract

Background: The purpose of our review is to analyze and compare the perioperative and clinicopathologic outcomes of laparoscopic-assisted rectal surgeries (LARS) and open rectal surgeries (ORS) for rectal malignancies. Patients and methods: A retrospective analysis of data available from June 2015 to October 2018 was performed. Patient's demographic profile, tumor characteristics, perioperative, and short-term clinicopathological outcomes were compiled and contrasted. Statistical tests used were Student's t test and Fischer's exact test. Results: During the study period, 34 and 24 patients underwent laparoscopic and open rectal cancer surgeries, respectively. Of 58 patients, there were 30 men (51.7%) and 28 women (48.3%) with average age group of 51.7 years. The median tumor distance was 4 cm and 6 cm from the anal verge in the laparoscopic and open groups, respectively (p = 0.03). 70.1% of patients underwent preoperative chemoradiation. Conversion rate noted was 14.7%. Operative duration was prolonged for laparoscopic resection (194.7 vs 178.3 minutes, p = 0.168). Blood loss (395.58 vs 506.66 mL), postoperative hospital stay (8.3 vs 11.5 days: mean difference, 3.2 days), 30-day mortality (3% vs 0% p = 0.81), and major complications (11.8% vs 16.7%) failed to differ significantly. Negative circumferential radial margin was noticed in 98.4% of the overall group (94.1% laparoscopic resection and 95.8% open resection; p = 0.93). Conclusion: There were certainly no significant differences between laparoscopic and open surgeries in operative time period, complications, and duration of hospital stay. Hence, laparoscopic surgery is oncologically safe in rectal cancer patients. Clinical significance: Laparoscopic rectal cancer surgeries could be feasible with equivalent short-term outcomes as with open surgeries with less morbidity, even among patients treated with preoperative chemoradiation.


HTML PDF Share
  1. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986;1:1479–1482. DOI: 10.1016/S0140-6736(86)91510-2.
  2. Keller DS, Qiu J, et al. Predicting opportunities to increase utilization of laparoscopy for rectal cancer. Surg Endosc 2018;32:1556–2663. DOI: 10.1007/s00464-017-5844-y.
  3. Cecil TD, Taffinder N, et al. A personal view on laparoscopic rectal cancer surgery. Colorectal Dis 2006;8(3):30–32. DOI: 10.1111/j.1463-1318.2006.01068.x.
  4. Zhang FW, Zhou ZY, et al. Laparoscopic versus open surgery for rectal cancer: a systematic review and meta-analysis of randomized controlled trials. Asian Pac J Cancer Prev 2014;15:9985–9996. DOI: 10.7314/APJCP.2014.15.22.9985.
  5. Piątkowski J, Jackowski M, et al. Trans anal total mesorectal excision (TATME) – preliminary findings. Videosurgery Miniinv 2015;10: 495–498. DOI: 10.5114/wiitm.2015.54060.
  6. Fleshman J, Branda M, et al. Effect of laparoscopic- assisted resection vs. open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA 2015;314:1346–1355. DOI: 10.1001/jama.2015.10529.
  7. van der Pas MH, Haglind E, et al. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol 2013;14:210–218. DOI: 10.1016/S1470-2045(13)70016-0.
  8. Stevenson AR, Solomon MJ, et al. Effect of laparoscopic- assisted resection vs. open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA 2015;314: 1356–1363. DOI: 10.1001/jama.2015.12009.
  9. Pędziwiatr M, Małczak P, et al. There is no difference in outcome between laparoscopic and open surgery for rectal cancer: a systematic review and meta-analysis on short- and long-term oncologic outcomes. Tech Coloproctology 2017;21:595–604. DOI: 10.1007/s10151-017-1662-4.
  10. Kang SB, Park JW, et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol 2010;11:637–645. DOI: 10.1016/S1470-2045(10)70131-5.
  11. Jeong SY, Park JW, et al. Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, noninferiority, randomised controlled trial. Lancet Oncol 2014;15:767–774. DOI: 10.1016/S1470-2045(14)70205-0.
  12. van der Pas MH, Haglind E, et al. Colorectal cancer Laparoscopic or Open Resection II (COLOR II) Study Group. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol 2013;14(3):210–218. DOI: 10.1016/S1470-2045(13)70016-0.
  13. Guillou PJ, Quirke P, et al. MRC CLASICC trial group. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 2005;365(9472):1718–1726. DOI: 10.1016/S0140-6736(05)66545-2.
  14. Jayne DG, Thorpe HC, et al. Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg 2010;97(11):1638–1645. DOI: 10.1002/bjs.7160.
  15. Jayne DG, Guillou PJ, et al. UK MRC CLASICC Trial Group. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol 2007;25(21):3061–3068. DOI: 10.1200/JCO.2006.09.7758.
  16. Arezzo A, Passera R, et al. Laparoscopy for rectal cancer reduces short-term mortality and morbidity: results of a systematic review and meta-analysis. Surg Endosc 2013;27(5):1485–1502. DOI: 10.1007/s00464-012-2649-x.
  17. Boutros M, Hippalgaonkar N, et al. Laparoscopic resection of rectal cancer results in higher lymph node yield and better short-term outcomes than open surgery: a large single-centre comparative study. Dis Colon Rectum 2013;56(6):679–688. DOI: 10.1097/DCR.0b013e318287c594.
  18. Lee SD, Park SC, et al. Laparoscopic versus open surgery for stage I rectal cancer: long-term oncologic outcomes. World J Surg 2013;37(3):646–651. DOI: 10.1007/s00268-012-1846-z.
  19. Birbeck KF, Macklin CP, et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 2002;235(4):449–457. DOI: 10.1097/00000658-200204000-00001.
  20. Lujan J, Valero G. Laparoscopic versus open surgery for rectal cancer: results of a prospective multicentre analysis of 4,970 patients. Surg Endosc 2013;27(1):295–302. DOI: 10.1007/s00464-012- 2444-8.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.